GREENHEART GP Interim 2026: Net Loss Contracts to HK$11.72 Million as NZ Asset Sale Strengthens Balance Sheet

Bulletin Express
09/16

Greenheart Group Limited (“GREENHEART GP”) reported a sharply narrower net loss of HK$11.72 million for the six months ended 30 June 2026, an 88.0% improvement from the HK$97.60 million deficit a year earlier. The turnaround was driven by a HK$26.75 million gain on the disposal of most of the Mangakahia and Ormond Valley forests in New Zealand and the absence of losses from the previously divested Suriname division.

Revenue from continuing operations (New Zealand forestry and management services) declined 7.8% year-on-year to HK$19.03 million as radiata pine export volumes and prices softened. Nonetheless, gross profit rose 11.1% to HK$2.15 million, lifting gross margin to 11.3% (1H 2025: 9.4%) on higher-margin forest management services.

EBITDA from continuing operations dropped to HK$0.74 million (1H 2025: HK$11.15 million) after a HK$9.11 million fair-value loss on plantation assets. Administrative expenses rose 57.8% to HK$24.92 million, reflecting post-harvest cleaning costs and a one-off staff bonus.

The NZ$133.47 million (HK$626.82 million) asset sale, completed on 30 January 2026, significantly boosted liquidity. Cash and bank balances jumped to HK$520.12 million from HK$39.85 million at year-end 2025, while bank borrowings were fully repaid. Total debt now consists mainly of shareholder loans, reducing the gearing ratio to 76.9% (31 December 2025: 81.4%).

Net assets stood at HK$145.50 million versus HK$185.35 million at year-end, after the HK$27.83 million special dividend paid in March 2026. No interim dividend was declared.

Looking forward, management expects elevated shipping and operating costs to constrain margins but believes the strengthened balance sheet positions the group to pursue mature cutting-right acquisitions across Asia-Pacific under a disciplined capital-allocation framework. Post-period, an intra-group loan default event between subsidiaries is under review; no external creditor exposure was disclosed.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10